financetom
Business
financetom
/
Business
/
Uruguay's DLocal Q2 revenue up 50%, beats analyst expectations
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Uruguay's DLocal Q2 revenue up 50%, beats analyst expectations
Aug 13, 2025 1:47 PM

Overview

* DLocal Q2 2025 revenue up 50% yr/yr, beating analyst expectations, per LSEG data

* Adjusted EBITDA for Q2 2025 rises 64% yr/yr, beating analyst expectations, per LSEG data

* Company raises full-year 2025 guidance for TPV, revenue, gross profit, and adjusted EBITDA

Outlook

* Dlocal ( DLO ) raises 2025 TPV growth guidance to 40%-50% YoY

* Company expects 2025 revenue growth of 30%-40% YoY

* Dlocal ( DLO ) anticipates 2025 gross profit growth of 27.5%-37.5% YoY

* Company sees 2025 adjusted EBITDA growth of 40%-50% YoY

Result Drivers

* TPV GROWTH - Total Payment Volume reached a record $9.2 bln, up 53% yr/yr, driven by strong results in Brazil and Mexico and fastest growth in other geographies

* REVENUE INCREASE - Revenue rose 50% yr/yr to $256.5 mln, exceeding TPV growth due to a higher share of pay-ins, partially offset by volume loss in Egypt

Key Details

Metric Beat/Mis Actual Consensu

s s

Estimate

Q2 Beat $256.50 $229.70

Revenue mln mln (5

Analysts

)

Q2 Beat $70.10 $53.90

Adjusted mln mln (5

EBITDA Analysts

)

Q2 Gross 39.0%

Margin

Q2 27.0%

Adjusted

EBITDA

Margin

Q2 Gross $98.90

Profit mln

Analyst Coverage

* The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 3 "strong buy" or "buy", 6 "hold" and no "sell" or "strong sell"

* The average consensus recommendation for the business support services peer group is "buy."

* Wall Street's median 12-month price target for Dlocal Ltd ( DLO ) is $11.25, about 2.5% above its August 12 closing price of $10.97

* The stock recently traded at 16 times the next 12-month earnings vs. a P/E of 13 three months ago

Press Release:

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Blackstone ups offer for UK's Warehouse REIT to $666 million
Blackstone ups offer for UK's Warehouse REIT to $666 million
Jul 10, 2025
July 10 (Reuters) - Blackstone said on Thursday it had raised its offer to buy Warehouse REIT to 115 pence per share, valuing the British firm at about 489 million pounds ($665.6 million). ($1 = 0.7346 pounds) ...
Pakistan eyes $1 billion valuation in Roosevelt Hotel redevelopment plan, source says
Pakistan eyes $1 billion valuation in Roosevelt Hotel redevelopment plan, source says
Jul 10, 2025
KARACHI (Reuters) -Pakistan is seeking a valuation of at least $1 billion for the Roosevelt Hotel it owns in New York and is ready to part with a minority stake in the prime Manhattan property as it scouts for a redevelopment partner, a senior government official said. Named after former U.S. President Theodore Roosevelt, the century-old property in midtown Manhattan...
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Aug 17, 2025
SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...
Nurix Therapeutics Fiscal Q2 Loss Narrows, Revenue More Than Triples; Shares Surge Premarket
Nurix Therapeutics Fiscal Q2 Loss Narrows, Revenue More Than Triples; Shares Surge Premarket
Jul 10, 2025
05:27 AM EDT, 07/10/2025 (MT Newswires) -- Nurix Therapeutics ( NRIX ) reported a fiscal Q2 net loss late Wednesday of $0.52 per diluted share, compared with a $0.71 loss a year earlier. Analysts polled by FactSet expected a $0.71 loss. Revenue for the quarter ended May 31 was $44.1 million, up from $12.1 million a year earlier. Analysts surveyed...
Copyright 2023-2026 - www.financetom.com All Rights Reserved